tiprankstipranks
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
US Market
Want to see KRMD full AI Analyst Report?

REPRO-MED Systems (KRMD) Stock Statistics & Valuation Metrics

296 Followers

Total Valuation

REPRO-MED Systems has a market cap or net worth of $148.21M. The enterprise value is $202.96.
Market Cap$148.21M
Enterprise Value$202.96

Share Statistics

REPRO-MED Systems has 46,171,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,171,900
Owned by Insiders17.42%
Owned by Institutions22.74%

Financial Efficiency

REPRO-MED Systems’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -14.47%.
Return on Equity (ROE)-0.15
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-14.47%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee563.39K
Profits Per Employee-36.14K
Employee Count73
Asset Turnover1.46
Inventory Turnover4.22

Valuation Ratios

The current PE Ratio of REPRO-MED Systems is ―. REPRO-MED Systems’s PEG ratio is 1.81.
PE Ratio
PS Ratio6.52
PB Ratio15.74
Price to Fair Value15.74
Price to FCF-570.81
Price to Operating Cash Flow106.35
PEG Ratio1.81

Income Statement

In the last 12 months, REPRO-MED Systems had revenue of 41.13M and earned -2.64M in profits. Earnings per share was -0.06.
Revenue41.13M
Gross Profit25.60M
Operating Income-2.97M
Pretax Income-2.62M
Net Income-2.64M
EBITDA-1.81M
Earnings Per Share (EPS)-0.06

Cash Flow

In the last 12 months, operating cash flow was 1.39M and capital expenditures -1.13M, giving a free cash flow of 263.47K billion.
Operating Cash Flow1.39M
Free Cash Flow263.47K
Free Cash Flow per Share<0.01

Dividends & Yields

REPRO-MED Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.98
52-Week Price Change-24.65%
50-Day Moving Average3.95
200-Day Moving Average4.55
Relative Strength Index (RSI)29.90
Average Volume (3m)198.68K

Important Dates

REPRO-MED Systems upcoming earnings date is Nov 11, 2026, After Close (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date

Financial Position

REPRO-MED Systems as a current ratio of 2.44, with Debt / Equity ratio of 17.94%
Current Ratio2.44
Quick Ratio1.99
Debt to Market Cap0.01
Net Debt to EBITDA2.98
Interest Coverage Ratio0.00

Taxes

In the past 12 months, REPRO-MED Systems has paid 21.89K in taxes.
Income Tax21.89K
Effective Tax Rate>-0.01

Enterprise Valuation

REPRO-MED Systems EV to EBITDA ratio is -145.65, with an EV/FCF ratio of -559.38.
EV to Sales6.39
EV to EBITDA-145.65
EV to Free Cash Flow-559.38
EV to Operating Cash Flow568.70

Balance Sheet

REPRO-MED Systems has $8.29M in cash and marketable securities with $3.24M in debt, giving a net cash position of $5.05M billion.
Cash & Marketable Securities$8.29M
Total Debt$3.24M
Net Cash$5.05M
Net Cash Per Share$0.11
Tangible Book Value Per Share$0.35

Margins

Gross margin is 61.99%, with operating margin of -7.23%, and net profit margin of -6.41%.
Gross Margin61.99%
Operating Margin-7.23%
Pretax Margin-6.36%
Net Profit Margin-6.41%
EBITDA Margin-4.39%
EBIT Margin-6.36%

Analyst Forecast

The average price target for REPRO-MED Systems is $6.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.60
Price Target Upside72.32% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast22.41%
EPS Growth Forecast60.02%

Scores

Smart Score4
AI Score